Abrogation of TNFα production during cancer immunotherapy is crucial for suppressing side effects due to the systemic expression of IL-12. (Q35108695)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Abrogation of TNFα production during cancer immunotherapy is crucial for suppressing side effects due to the systemic expression of IL-12. |
scientific article |
Statements
1 reference
Abrogation of TNFα production during cancer immunotherapy is crucial for suppressing side effects due to the systemic expression of IL-12. (English)
1 reference
Bibiana Barrios
1 reference
Natalia S Baez
1 reference
Della Reynolds
1 reference
Pablo Iribarren
1 reference
Hugo Cejas
1 reference
Howard A Young
1 reference
Maria Cecilia Rodriguez-Galan
1 reference
28 February 2014
1 reference
1 reference
9
1 reference
2
1 reference
e90116
1 reference
28 February 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference